| Financial Year |
March 31 2023 |
| Monetary Funds |
5,812,061,267.12 |
| Held-for-trading Financial Assets |
5,125,791,175.80 |
| Notes Receivable |
-- |
| Accounts Receivable |
939,358,424.21 |
| Advances to Suppliers |
-- |
| Other Receivables |
238,292,090.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
36,001,986,072.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,602,658,780.54 |
| Total Current Assets |
59,480,881,092.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
12,898,092,353.12 |
| Investment Properties |
39,420,670,781.06 |
| Fixed Assetes |
3,743,251,883.98 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
43,472,232.55 |
| R&D expenses |
-- |
| Goodwill |
870,922,005.04 |
| Long-Term Deferred and Prepaid Expenses |
134,783,442.96 |
| Deferred Income Tax Assets |
1,798,551,836.28 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
66,338,599,136.90 |
| Total Assets |
125,819,480,229.07 |
| Short-Term Loans |
15,529,550,326.74 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
3,735,878,179.03 |
| Accounts Received In Advance |
720,793,938.32 |
| Employee Compensation Payable |
75,830,911.42 |
| Taxes Payable |
1,746,316,754.22 |
| Interest Payable |
-- |
| Dividend Payable |
334,612.41 |
| Other payables |
7,881,101,505.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,292,692,157.70 |
| Other Current Liabilities |
3,571,542,778.90 |
| Sub-Total of Current Liabilities |
51,769,410,099.52 |
| Long-term Loans |
10,214,489,632.16 |
| Bonds Payable |
24,081,294,000.00 |
| Long-Term Accounts Payable |
219,308,056.74 |
| Special Payable |
-- |
| Estimatied Liabilities |
25,671,576.85 |
| Deferred Income Tax Liabilities |
21,816,911.66 |
| Other Non-Current Liabilities |
1,139,762,060.32 |
| Sub-Total of Non-Current Liabilities |
35,800,387,351.87 |
| Total Liabilities |
87,569,797,451.39 |
| Paid-In Capital(Or Share Stock) |
4,034,197,440.00 |
| Capital Surplus |
45,543,150.60 |
| Surplus Reserve |
2,674,523,845.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
14,729,378,719.78 |
| Minority Stockholder's Interest |
16,241,118,147.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
22,008,564,630.05 |
| Owner's Equity（Stockholder's Equity） |
38,249,682,777.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
125,819,480,229.07 |
